undamentalytics Newsletter
Sign in

Boston Scientific cash flow statement

In fiscal 2025, Boston Scientific's operations generated $4.53bn of cash; it spent $876m on capital projects, leaving free cash flow of $3.66bn.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations8353251,0081,2801,1101,2696911,1821,4263101,8361,5081,8701,5262,5033,4354,5344,234
Depreciation and amortisation8348167176836897257698158448941,0111,1231,0931,1361,1961,2691,3681,432
Stock-based pay144150128108105103107116127140157170194220233266299313
Capital spending312272304226245259247376319316461376554588711790876903
Free cash flow523537041,0548651,0104448061,107−61,3751,1321,3169381,7922,6453,6583,331
Free cash flow after stock pay379−97576946760907337690980−1461,2189621,1227181,5592,3793,3593,018
Dividends paid—————————00285555280——
Share buybacks——49260050012500—0053500————
Shares issued333121217460114111850097500————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BSX vs GEHCBSX vs PHGBSX vs SYK

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Boston Scientific's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Boston Scientific.